Vimarsana
Biggest News Aggregation in the World

Page 17 - Tender Offer Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tender Offer Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tender Offer Statement Today - Breaking & Trending Today

Nano Dimension : Report Of Foreign Private Issuer - Vimarsana News

Nano Dimension : Report Of Foreign Private Issuer

CONTENTS On July 17, 2023, Nano Dimension Ltd. issued: a press release titled Nano Dimension Encourages Stratasys Shareholders to Replace Entrenched Board and Highlights...

Itaú Unibanco S A : Informação Prestada às Bolsas Estrangeiras - Vimarsana News

Itaú Unibanco S A : Informação Prestada às Bolsas Estrangeiras

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to ...

Mr. Cooper Extends Expiration Date of its Tender Offer to Acquire Home Point Capital - Vimarsana News

Mr. Cooper Extends Expiration Date of its Tender Offer to Acquire Home Point Capital

Mr. Cooper Group Inc. (NASDAQ: COOP) (“Mr. Cooper”) announced today that Heisman Merger Sub, Inc. (“Purchaser”), a wholly owned subsidiary of Mr. Cooper, has extended the expiration date of its offer (the “Offer”) to a...

VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals - VectivBio Holding (NASDAQ:VECT) - Vimarsana News

VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals - VectivBio Holding (NASDAQ:VECT)

BASEL, Switzerland, June 26, 2023 (GLOBE NEWSWIRE) -- VectivBio Holding AG ("VectivBio") (NASDAQ:VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare

VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals - Vimarsana News

VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals

BASEL, Switzerland, June 26, 2023 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditi...